Connection

Nima Rezaei to Coronavirus Infections

Back to Details
This is a "connection" page, showing publications Nima Rezaei has written about Coronavirus Infections.
Nima Rezaei
Connection Strength
0.803
Coronavirus Infections
  1. Interferon therapy in patients with SARS, MERS, and COVID-19: A systematic review and meta-analysis of clinical studies. Eur J Pharmacol. 2021 Sep 05; 906:174248.
    View in: PubMed
    Score: 0.030
  2. Regenerative Medicine in COVID-19 Treatment: Real Opportunities and Range of Promises. Stem Cell Rev Rep. 2021 02; 17(1):163-175.
    View in: PubMed
    Score: 0.029
  3. Anosmia: a missing link in the neuroimmunology of coronavirus disease 2019 (COVID-19). Rev Neurosci. 2020 10 25; 31(7):691-701.
    View in: PubMed
    Score: 0.028
  4. Human Coronaviruses SARS-CoV, MERS-CoV, and SARS-CoV-2 in Children. J Pediatr Nurs. 2021 Jan-Feb; 56:70-79.
    View in: PubMed
    Score: 0.028
  5. CRISPR/Cas13: A potential therapeutic option of COVID-19. Biomed Pharmacother. 2020 Nov; 131:110738.
    View in: PubMed
    Score: 0.028
  6. Cardiovascular system is at higher risk of affecting by COVID-19. Acta Biomed. 2020 09 07; 91(3):e2020018.
    View in: PubMed
    Score: 0.028
  7. Cytokines and COVID-19: friends or foes? Hum Vaccin Immunother. 2020 10 02; 16(10):2363-2365.
    View in: PubMed
    Score: 0.028
  8. Adrenal insufficiency in coronavirus disease 2019: a case report. J Med Case Rep. 2020 Aug 24; 14(1):134.
    View in: PubMed
    Score: 0.028
  9. Immunotherapy for SARS-CoV-2: potential opportunities. Expert Opin Biol Ther. 2020 10; 20(10):1111-1116.
    View in: PubMed
    Score: 0.028
  10. The immune system as a target for therapy of SARS-CoV-2: A systematic review of the current immunotherapies for COVID-19. Life Sci. 2020 Oct 01; 258:118185.
    View in: PubMed
    Score: 0.028
  11. Angiotensin-converting enzyme 2 (ACE2) receptor and SARS-CoV-2: Potential therapeutic targeting. Eur J Pharmacol. 2020 Oct 05; 884:173455.
    View in: PubMed
    Score: 0.028
  12. COVID-19: A Chimera of Two Pandemics. Disaster Med Public Health Prep. 2020 Jun; 14(3):e38-e39.
    View in: PubMed
    Score: 0.028
  13. Monoclonal antibody as a potential anti-COVID-19. Biomed Pharmacother. 2020 Sep; 129:110337.
    View in: PubMed
    Score: 0.028
  14. Lymphopenia in COVID-19: Therapeutic opportunities. Cell Biol Int. 2020 Sep; 44(9):1792-1797.
    View in: PubMed
    Score: 0.028
  15. The immune system and COVID-19: Friend or foe? Life Sci. 2020 Sep 01; 256:117900.
    View in: PubMed
    Score: 0.028
  16. Case Report: Death due to COVID-19 in Three Brothers. Am J Trop Med Hyg. 2020 06; 102(6):1203-1204.
    View in: PubMed
    Score: 0.028
  17. All together to Fight COVID-19. Am J Trop Med Hyg. 2020 06; 102(6):1181-1183.
    View in: PubMed
    Score: 0.028
  18. Interleukin-6 and severe COVID-19: a systematic review and meta-analysis. Eur Cytokine Netw. 2020 Jun 01; 31(2):44-49.
    View in: PubMed
    Score: 0.028
  19. SARS-CoV-2-A Tough Opponent for the Immune System. Arch Med Res. 2020 08; 51(6):589-592.
    View in: PubMed
    Score: 0.028
  20. COVID-19: Transmission, prevention, and potential therapeutic opportunities. Clin Chim Acta. 2020 Sep; 508:254-266.
    View in: PubMed
    Score: 0.028
  21. The involvement of the central nervous system in patients with COVID-19. Rev Neurosci. 2020 05 26; 31(4):453-456.
    View in: PubMed
    Score: 0.028
  22. The urgent need for integrated science to fight COVID-19 pandemic and beyond. J Transl Med. 2020 05 19; 18(1):205.
    View in: PubMed
    Score: 0.028
  23. Towards treatment planning of COVID-19: Rationale and hypothesis for the use of multiple immunosuppressive agents: Anti-antibodies, immunoglobulins, and corticosteroids. Int Immunopharmacol. 2020 Jul; 84:106560.
    View in: PubMed
    Score: 0.028
  24. Genetic predisposition models to COVID-19 infection. Med Hypotheses. 2020 09; 142:109818.
    View in: PubMed
    Score: 0.028
  25. Borderless collaboration is needed for COVID-19-A disease that knows no borders. Infect Control Hosp Epidemiol. 2020 Oct; 41(10):1245-1246.
    View in: PubMed
    Score: 0.027
  26. COVID-19 affects healthy pediatricians more than pediatric patients. Infect Control Hosp Epidemiol. 2020 Sep; 41(9):1106-1107.
    View in: PubMed
    Score: 0.027
  27. Immune-epidemiological parameters of the novel coronavirus - a perspective. Expert Rev Clin Immunol. 2020 05; 16(5):465-470.
    View in: PubMed
    Score: 0.027
  28. COVID-19 and telemedicine: Immediate action required for maintaining healthcare providers well-being. J Clin Virol. 2020 05; 126:104345.
    View in: PubMed
    Score: 0.027
  29. The prevalence of post-traumatic stress disorder related symptoms in Coronavirus outbreaks: A systematic-review and meta-analysis. J Affect Disord. 2021 03 01; 282:527-538.
    View in: PubMed
    Score: 0.007
  30. Viewpoint: Origin of SARS-CoV-2. Viruses. 2020 10 22; 12(11).
    View in: PubMed
    Score: 0.007
  31. International Efforts to Save Healthcare Personnel during COVID-19. Acta Biomed. 2020 09 07; 91(3):e2020044.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.